Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy.
about
Immunoregulatory functions of immune complexes in vaccine and therapyRecent Advances in Clinical Glycoproteomics of Immunoglobulins (Igs)Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia.IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity.Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine.HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1.B-cell-independent sialylation of IgG.Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.Germinal center selection and the antibody response to influenzaFcγ receptor pathways during active and passive immunization.Waning Immunity and Microbial Vaccines-Workshop of the National Institute of Allergy and Infectious Diseases.The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificityImmunoglobulin Glycosylation Effects in Allergy and Immunity.The Role and Function of Fcγ Receptors on Myeloid Cells.Anti-retroviral antibody FcγR-mediated effector functions.Signaling by Antibodies: Recent Progress.Increasing the breadth and potency of response to the seasonal influenza virus vaccine by immune complex immunization.Conformational modulation of influenza virus hemagglutinin: characterization and in vivo efficacy of monomeric form.Generation of a Mutant Mucor hiemalis Endoglycosidase That Acts on Core-fucosylated N-Glycans.The direct and indirect effects of glycans on immune function.Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease.Fcγ Receptor Function and the Design of Vaccination Strategies.Sweet SIGNs: IgG glycosylation leads the way in IVIG-mediated resolution of inflammation.Diversification of IgG effector functions.Potential of Murine IgG1 and Human IgG4 to Inhibit the Classical Complement and Fcγ Receptor Activation Pathways.Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy.The Role of Fc Gamma Receptors in Broad Protection against Influenza VirusesStrategies for a multi-stage neutralizing antibody-based HIV vaccine
P2860
Q26738396-5FF6D05A-F304-41FD-9751-C58A8C7F0FF6Q26752274-57BC63B8-5D46-49DC-8C7D-2268CB0D68A8Q30393724-B8B97A34-4955-4363-8D87-28F7BF5541EEQ33431066-A30D3744-67E6-420C-8388-4CF9242EF16DQ33438726-A38113AE-80BC-4C87-9DA6-D7395C3D690CQ34520430-F6D954A7-2BF7-4DE6-A9CF-1DF480032989Q34527469-2527C403-E48D-4E59-BC0E-2A1497E935E1Q37065114-8FA2E83D-EF00-4EC7-9D3E-AC7ACEBF31FAQ37369509-D44CE3CA-CF0F-43E0-9E13-F37249C4863EQ38615063-0F51C097-62D4-419D-ADC7-9D4344AB0A98Q38615357-2BF85BB7-A0F5-4BB6-AF49-CECF8C19AC69Q38685505-D922E529-9154-45C6-842B-CAC3C35CC41FQ38767298-18AD564E-1C63-487B-BED0-82D7F2B6B151Q38994739-7DE08614-6A74-4CAC-9350-7853D98AB8A6Q39088502-094A70E5-D6A6-409A-8381-73C2489E52DFQ39108744-931D0602-30A2-4639-9901-E2069E43ECACQ39264890-2112F36A-2038-444D-AEBA-449B7A71554BQ40056879-0A651414-853D-4659-804D-32E75F47EEABQ40090039-89378E71-B1DA-4DCB-9BB5-16B3D8A91D13Q42725794-42985B85-EE41-45C1-9E67-655BB93881E2Q46632825-DA2D589A-2342-442D-B1E9-0780E788B938Q47220975-3438A532-EBA9-4BAE-96DA-DCAB8129300BQ47945550-2AAB1ED0-84AD-4B1C-AFAD-A9FF6C9BC176Q50193260-F9898144-A32F-45D3-8755-49B53D26A05AQ53313488-EE2E89D5-97FB-426B-A53F-AFCCF119F932Q55250588-DC185DD3-1A31-444B-BB19-6EC53CF4ABAAQ55689231-2F5EF170-F965-4108-BD32-0B21D4D0E87DQ57019841-878988AA-2E05-4C31-BB78-0F0F9CBD2316Q57171873-DC753081-8D46-42EF-899F-340F964B143C
P2860
Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Anti-HA Glycoforms Drive B Cel ...... ne Influenza Vaccine Efficacy.
@ast
Anti-HA Glycoforms Drive B Cel ...... ne Influenza Vaccine Efficacy.
@en
type
label
Anti-HA Glycoforms Drive B Cel ...... ne Influenza Vaccine Efficacy.
@ast
Anti-HA Glycoforms Drive B Cel ...... ne Influenza Vaccine Efficacy.
@en
prefLabel
Anti-HA Glycoforms Drive B Cel ...... ne Influenza Vaccine Efficacy.
@ast
Anti-HA Glycoforms Drive B Cel ...... ne Influenza Vaccine Efficacy.
@en
P2093
P2860
P50
P1433
P1476
Anti-HA Glycoforms Drive B Cel ...... ne Influenza Vaccine Efficacy.
@en
P2093
Carl W Davis
Jad Maamary
Jeffrey V Ravetch
Rafi Ahmed
Sarah J Schlesinger
Stylianos Bournazos
Taia T Wang
P2860
P304
P356
10.1016/J.CELL.2015.06.026
P407
P577
2015-07-01T00:00:00Z